Atom Investors’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
Atom Investors's IMNM Position: Q3 2026 in Review
Atom Investors increased its Immunome (IMNM) stake by 104% in Q3 2026, buying an estimated $7.71M and bringing the position to 608,277 shares worth $13.1M. The position accounts for 0.73% of the portfolio, ranked #10.
Atom Investors first reported a position in IMNM in Q4 2021 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.
- Atom Investors held 608,277 shares of Immunome worth $13.1M as of Q3 2026.
- Atom Investors bought 310,788 Immunome shares in Q3 2026, an estimated $7.71M.
- Immunome made up 0.73% of Atom Investors's portfolio in Q3 2026, its #10 holding.
- Atom Investors first reported a position in Immunome in Q4 2021 and has held it in 6 quarters since.
- 211 funds tracked by Wall St. Rank held Immunome as of Q3 2026.
Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.